Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone for Binge Drinking in MSM (SayWhen)
NCT02330419Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Apr 2015
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of naltrexone in alcohol use disorder (AUD), sponsored by University of California, San Francisco. Primary endpoints: Binge Drinking Days Per Week at 12 weeks and Positive Ethyl Glucuronide Tests at 12 weeks. Started Apr 2015; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02330419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02330419.